PRINCETON, N.J.--(EON: Enhanced Online News)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that five scientific abstracts based on commercial and development-stage products in the Company
Honey a Low Cost Treatment for HIV Patients with Venous Ulcers
PRINCETON, N.J.--(EON: Enhanced Online News)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that five scientific abstracts based on commercial and development-stage products in the Company
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment